0001104659-22-125907.txt : 20221209 0001104659-22-125907.hdr.sgml : 20221209 20221209165044 ACCESSION NUMBER: 0001104659-22-125907 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221208 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221209 DATE AS OF CHANGE: 20221209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arbor Rapha Capital Bioholdings Corp. I CENTRAL INDEX KEY: 0001855886 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 862427174 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40967 FILM NUMBER: 221455386 BUSINESS ADDRESS: STREET 1: 333 EARLE OVINGTON BLVD., SUITE 900 CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: (516) 506-4200 MAIL ADDRESS: STREET 1: 333 EARLE OVINGTON BLVD., SUITE 900 CITY: UNIONDALE STATE: NY ZIP: 11553 8-K 1 tm2232382d1_8k.htm FORM 8-K
0001855886 false --12-31 0001855886 2022-12-08 2022-12-08 0001855886 arcku:UnitsEachConsistingOfOneShareOfClassCommonStockAndOnethirdOfOneRedeemableWarrantMember 2022-12-08 2022-12-08 0001855886 us-gaap:CommonClassAMember 2022-12-08 2022-12-08 0001855886 arcku:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member 2022-12-08 2022-12-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): December 8, 2022

 

Arbor Rapha Capital Bioholdings Corp. I

(Exact name of registrant as specified in its charter)

 

Delaware   001-40967   82-2427174

(State or other jurisdiction

of incorporation)

   (Commission
File Number)		  

(I.R.S. Employer

Identification No.)

 

333 Earle Ovington Blvd. Suite 900 Uniondale, NY   11553
(Address of principal executive offices)   (Zip Code)

 

(516) 506-4200

(Registrant’s telephone number, including area code)

 

Not Applicable 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant   ARCKU   The Nasdaq Stock Market
Class A common stock, par value $0.0001 per share   ARCK   The Nasdaq Stock Market
Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50   ARCKW   The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company      x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Class A common stock

 

 

 

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

The information disclosed in Item 5.07 of this Current Report on Form 8-K under the headings “Proposal 1” and “Proposal 2” is incorporated by reference into this Item 5.03 to the extent required herein.

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

Special Meeting

 

On December 8, 2022, Arbor Rapha Capital Bioholdings Corp. I, a Delaware corporation (the “Company”, “we” or “our”), held a special meeting (the “Special Meeting”) in person, at which holders of 18,939,649 ordinary shares, comprised of 14,627,149 shares of Class A common stock, par value $0.0001 per share, of the Company (“Class A Common Stock”), and 4,312,500 shares of Class B common stock, par value $0.0001 per share, of the Company (“Class B Common Stock”, collectively with the Class A Common Stock, the “Common Stock”), were present in person or by proxy, representing approximately 87.83% of the voting power of the 21,562,500 issued and outstanding shares of the Company’s Common Stock, comprised of (i) 17,250,000 shares of Class A Common Stock and (ii) 4,312,500 shares of Class B Common Stock, entitled to vote at the Special Meeting at the close of business on October 28, 2022, which was the record date (the “Record Date”) for the Special Meeting. The Company’s stockholders of record as of the close of business on the Record Date are referred to herein as “Stockholders.”

 

Proposal 1

 

The Stockholders approved, by special resolution, the proposal to amend the Company’s Amended and Restated Certificate of Incorporation ( the “Certificate of Incorporation”) to extend the date by which the Company must either (i) consummate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, involving the Company with one or more businesses, which we refer to as our “initial Business Combination”, or (ii) cease its operations, except for the purpose of winding up if it fails to complete such initial Business Combination, and redeem all of the Company’s shares of Class A Common Stock, and all of its shares of Class B Common Stock, included as part of the units sold in the Company’s initial public offering that was consummated on November 2, 2021, from February 2, 2023 to August 2, 2023 (the “Extension Amendment”). The voting results for such proposal were as follows:

 

For  Against  Abstain  Broker Non-Votes
18,573,809  365,840  0  0

 

On December 9, 2022, to effectuate the Extension Amendment, the board of directors of the Company (the “Board”) filed with the Secretary of State of the State of Delaware the Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company (the “Charter Amendment”). The foregoing description of the Charter Amendment does not purport to be complete and is qualified in its entirety by the terms of the Charter Amendment, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference.

 

Proposal 2

 

The Stockholders approved, by special resolution, the proposal to amend the Company’s Certificate of Incorporation to eliminate from the Certificate of Incorporation the limitation that the Company may not redeem public shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Securities Exchange Act of 1934) of less than $5,000,001 (the “Redemption Limitation”) in order to allow the Company to redeem public shares irrespective of whether such redemption would exceed the Redemption Limitation (the “Redemption Limitation Amendment”). The voting results for such proposal were as follows:

 

For  Against  Abstain  Broker Non-Votes
18,598,809  340,840  0  0

 

On December 9, 2022, to effectuate the Redemption Limitation Amendment, the Board filed with the Secretary of State of the State of Delaware the Charter Amendment. The foregoing description of the Charter Amendment does not purport to be complete and is qualified in its entirety by the terms of the Charter Amendment, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference.

 

1

 

 

Proposal 3

 

The proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there were insufficient votes for, or otherwise in connection with, the Extension Amendment, was not presented at the Special Meeting, as the Extension Amendment received a sufficient number of votes required for approval.

 

Item 8.01 Other Events.

 

Stockholders elected to redeem an aggregate of 17,188,668 shares of Class A Common Stock, representing approximately 99.6% of the issued and outstanding Class A Common Stock.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.  Description
3.1  Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company
104  Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 9, 2022

 

  Arbor Rapha Capital Bioholdings Corp. I
     
  By: /s/ Ivan Kaufman
  Name: Ivan Kaufman
  Title: Chief Executive Officer

 

 

 EX-3.1 2 tm2232382d1_ex3-1.htm EXHIBIT 3.1

 

Exhibit 3.1

 

CERTIFICATE OF AMENDMENT
TO THE
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF


ARBOR RAPHA CAPITAL BIOHOLDINGS CORP. I

December 9, 2022

 

Arbor Rapha Capital Bioholdings Corp. I (the “Company”), a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows:

 

FIRST: Article IX, Section 9.1(b) is hereby amended and restated in its entirety to read as follows:

 

“(b) Immediately after the Offering, a certain amount of the net offering proceeds received by the Corporation in the Offering (including the proceeds of any exercise of the underwriters’ over-allotment option) and certain other amounts specified in the Corporation’s registration statement on Form S-1, as initially filed with the Securities and Exchange Commission (the “SEC”) on September 14, 2021, as amended (the “Registration Statement”), shall be deposited in a trust account (the “Trust Account”), established for the benefit of the Public Stockholders (as defined below) pursuant to a trust agreement described in the Registration Statement. Except for the withdrawal of interest to pay taxes, none of the funds held in the Trust Account (including the interest earned on the funds held in the Trust Account) will be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of 100% of the Offering Shares (as defined below) if the Corporation is unable to complete its initial Business Combination within 21 months from the closing of the Offering and (iii) the redemption of Offering Shares in connection with a vote seeking to amend any provisions of this Amended and Restated Certificate (A) to modify the substance or timing of the Corporation’s obligation to allow redemptions in connection with the Corporation’s initial Business Combination or to redeem 100% of the Offering Shares if the Corporation has not consummated an initial Business Combination within 21 months from the date of the closing of the Offering or (B) relating to stockholders’ rights or pre-initial Business Combination activity (as described in Section 9.7). Holders of shares of the Corporation’s Common Stock included as part of the units sold in the Offering (the “Offering Shares”) (whether such Offering Shares were purchased in the Offering or in the secondary market following the Offering and whether or not such holders are Arbor Rapha Capital LLC (the “Sponsor”) or officers or directors of the Corporation, or affiliates of any of the foregoing) are referred to herein as “Public Stockholders.”

 

 

 

 

SECOND: Article IX, Section 9.2(d) is hereby amended and restated in its entirety to read as follows:

 

“(d) In the event that the Corporation has not consummated an initial Business Combination within 21 months from the closing of the Offering, the Corporation shall (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the Offering Shares in consideration of a per-share price, payable in cash, equal to the quotient obtained by dividing (A) the aggregate amount then on deposit in the Trust Account, including interest (net of taxes payable, and less up to $100,000 of such net interest to pay dissolution expenses), by (B) the total number of then outstanding Offering Shares, which redemption will completely extinguish rights of the Public Stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with applicable law, dissolve and liquidate, subject in each case to the Corporation’s obligations under the DGCL to provide for claims of creditors and other requirements of applicable law.”

 

THIRD: Article IX, Section 9.2(a) is hereby amended and restated in its entirety to read as follows:

 

“(a) Prior to the consummation of the initial Business Combination, the Corporation shall provide all holders of Offering Shares with the opportunity to have their Offering Shares redeemed (which redemption may be in the form of a repurchase by the Corporation) upon the consummation of the initial Business Combination pursuant to, and subject to the limitations of, Sections 9.2(b) and 9.2(c) (such rights of such holders to have their Offering Shares redeemed pursuant to such Sections, the “Redemption Rights”) hereof for cash equal to the applicable redemption price per share determined in accordance with Section 9.2(b) hereof (the “Redemption Price”). Notwithstanding anything to the contrary contained in this Amended and Restated Certificate, there shall be no Redemption Rights or liquidating distributions with respect to any warrant issued pursuant to the Offering.”

 

FOURTH: Article IX, Section 9.2(e) is hereby amended and restated in its entirety to read as follows:

 

“(e) If the Corporation offers to redeem the Offering Shares in conjunction with a stockholder vote on an initial Business Combination, the Corporation shall consummate the proposed initial Business Combination only if such initial Business Combination is approved by the affirmative vote of the holders of a majority of the shares of the Common Stock that are voted at a stockholder meeting held to consider such initial Business Combination (unless a greater vote is required by applicable law or stock exchange rules).”

 

FIFTH: Article IX, Section 9.2(f) is hereby amended by deleting Section 9.2(f) in its entirety.

 

 

 

 

SIXTH: Article IX, Section 9.7 is hereby amended and restated in its entirety to read as follows:

 

“Section 9.7 Additional Redemption Rights. If, in accordance with Section 9.1(a), any amendment is made to this Amended and Restated Certificate that would modify the substance or timing of the Corporation’s obligation to allow redemptions in connection with the Corporation’s initial Business Combination or to redeem 100% of the Offering Shares if the Corporation has not consummated an initial Business Combination within 21 months from the date of the closing of the Offering, or with respect to any other provision herein relating to stockholder’s rights or pre-initial Business Combination activity, the Public Stockholders shall be provided with the opportunity to redeem their Offering Shares upon the approval of any such amendment, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (net of taxes payable),divided by the number of then outstanding Offering Shares.”

  

SEVENTH: This amendment to the Amended and Restated Certificate of Incorporation of the Company was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware and by affirmative vote of the number of stockholders required to vote thereon.

 

3

 

 

IN WITNESS WHEREOF, Arbor Rapha Capital Bioholdings Corp. I has caused this Amendment to be duly executed in its name and on its behalf by an authorized officer as of the first date set forth above.

 

  ARBOR RAPHA CAPITAL BIOHOLDINGS CORP. I
   
  By: /s/ Ivan Kaufman
    Name: Ivan Kaufman
    Title: Chief Executive Officer

 

 

 

 

 EX-101.SCH 3 arcku-20221208.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 arcku-20221208_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 arcku-20221208_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Axis] Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant Class A common stock Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 arcku-20221208_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover
Dec. 08, 2022
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 08, 2022
Current Fiscal Year End Date --12-31
Entity File Number 001-40967
Entity Registrant Name Arbor Rapha Capital Bioholdings Corp. I
Entity Central Index Key 0001855886
Entity Tax Identification Number 82-2427174
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 333 Earle Ovington Blvd. Suite 900
Entity Address, City or Town Uniondale
Entity Address, State or Province NY
Entity Address, Postal Zip Code 11553
City Area Code 516
Local Phone Number 506-4200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant  
Title of 12(b) Security Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
Trading Symbol ARCKU
Security Exchange Name NASDAQ
Class A common stock  
Title of 12(b) Security Class A common stock, par value $0.0001 per share
Trading Symbol ARCK
Security Exchange Name NASDAQ
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50  
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
Trading Symbol ARCKW
Security Exchange Name NASDAQ
XML 8 tm2232382d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001855886 2022-12-08 2022-12-08 0001855886 arcku:UnitsEachConsistingOfOneShareOfClassCommonStockAndOnethirdOfOneRedeemableWarrantMember 2022-12-08 2022-12-08 0001855886 us-gaap:CommonClassAMember 2022-12-08 2022-12-08 0001855886 arcku:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member 2022-12-08 2022-12-08 iso4217:USD shares iso4217:USD shares 0001855886 false --12-31 8-K 2022-12-08 Arbor Rapha Capital Bioholdings Corp. I DE 001-40967 82-2427174 333 Earle Ovington Blvd. Suite 900 Uniondale NY 11553 516 506-4200 false false false false Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant ARCKU NASDAQ Class A common stock, par value $0.0001 per share ARCK NASDAQ Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 ARCKW NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 4 24 1 false 3 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://arborraphacapitalbioholdingscorp.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2232382d1_8k.htm arcku-20221208.xsd arcku-20221208_def.xml arcku-20221208_lab.xml arcku-20221208_pre.xml tm2232382d1_ex3-1.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2232382d1_8k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 4, "dts": { "definitionLink": { "local": [ "arcku-20221208_def.xml" ] }, "inline": { "local": [ "tm2232382d1_8k.htm" ] }, "labelLink": { "local": [ "arcku-20221208_lab.xml" ] }, "presentationLink": { "local": [ "arcku-20221208_pre.xml" ] }, "schema": { "local": [ "arcku-20221208.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 66, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 2, "memberStandard": 1, "nsprefix": "arcku", "nsuri": "http://arborraphacapitalbioholdingscorp.com/20221208", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2232382d1_8k.htm", "contextRef": "From2022-12-08to2022-12-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://arborraphacapitalbioholdingscorp.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2232382d1_8k.htm", "contextRef": "From2022-12-08to2022-12-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "arcku_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50" } } }, "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member", "nsuri": "http://arborraphacapitalbioholdingscorp.com/20221208", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "domainItemType" }, "arcku_UnitsEachConsistingOfOneShareOfClassCommonStockAndOnethirdOfOneRedeemableWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant" } } }, "localname": "UnitsEachConsistingOfOneShareOfClassCommonStockAndOnethirdOfOneRedeemableWarrantMember", "nsuri": "http://arborraphacapitalbioholdingscorp.com/20221208", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A common stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://arborraphacapitalbioholdingscorp.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 15 0001104659-22-125907-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-125907-xbrl.zip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end